Rosa Sebree

839 total citations
5 papers, 636 citations indexed

About

Rosa Sebree is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Rosa Sebree has authored 5 papers receiving a total of 636 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 1 paper in Pulmonary and Respiratory Medicine and 1 paper in Oncology. Recurrent topics in Rosa Sebree's work include Histone Deacetylase Inhibitors Research (4 papers), Epigenetics and DNA Methylation (4 papers) and Cancer-related gene regulation (4 papers). Rosa Sebree is often cited by papers focused on Histone Deacetylase Inhibitors Research (4 papers), Epigenetics and DNA Methylation (4 papers) and Cancer-related gene regulation (4 papers). Rosa Sebree collaborates with scholars based in United States and Canada. Rosa Sebree's co-authors include Rosalyn A. Juergens, Charles M. Rudin, Barbara Coleman, Frank P. Vendetti, Michelle A. Rudek, Malcolm V. Brock, Steven A. Belinsky, Stephen B. Baylin, Ming Zhao and Noreli Franco and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Cancer Discovery.

In The Last Decade

Rosa Sebree

5 papers receiving 628 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rosa Sebree United States	4	536	144	121	81	62	5	636
Ori Hassin Israel	6	307 0.6×	264 1.8×	136 1.1×	75 0.9×	65 1.0×	8	522
Jorg Michels Canada	8	280 0.5×	151 1.0×	71 0.6×	91 1.1×	85 1.4×	14	451
Yi Su China	12	374 0.7×	72 0.5×	100 0.8×	72 0.9×	46 0.7×	20	514
Danrui Cui China	14	563 1.1×	220 1.5×	92 0.8×	36 0.4×	40 0.6×	27	655
Shishan Deng China	13	390 0.7×	135 0.9×	177 1.5×	58 0.7×	59 1.0×	31	520
Janice M. Mehnert United States	8	303 0.6×	183 1.3×	58 0.5×	36 0.4×	52 0.8×	24	409
Kyle A. Edgar United States	12	336 0.6×	137 1.0×	43 0.4×	99 1.2×	39 0.6×	20	463
Zhuonan Liu China	8	445 0.8×	132 0.9×	159 1.3×	83 1.0×	53 0.9×	12	529
Chu Myong Seong South Korea	12	360 0.7×	133 0.9×	51 0.4×	50 0.6×	36 0.6×	30	511

Countries citing papers authored by Rosa Sebree

Since Specialization

Citations

This map shows the geographic impact of Rosa Sebree's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosa Sebree with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosa Sebree more than expected).

Fields of papers citing papers by Rosa Sebree

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosa Sebree. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosa Sebree. The network helps show where Rosa Sebree may publish in the future.

Co-authorship network of co-authors of Rosa Sebree

This figure shows the co-authorship network connecting the top 25 collaborators of Rosa Sebree. A scholar is included among the top collaborators of Rosa Sebree based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosa Sebree. Rosa Sebree is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Rudin, Charles M., Julie R. Brahmer, Rosalyn A. Juergens, et al.. (2013). Phase 2 Study of Pemetrexed and Itraconazole as Second-Line Therapy for Metastatic Nonsquamous Non–Small-Cell Lung Cancer. Journal of Thoracic Oncology. 8(5). 619–623. 117 indexed citations

2.

Juergens, Rosalyn A., John Wrangle, Frank P. Vendetti, et al.. (2011). Combination Epigenetic Therapy Has Efficacy in Patients with Refractory Advanced Non–Small Cell Lung Cancer. Cancer Discovery. 1(7). 598–607. 498 indexed citations

3.

Juergens, Rosalyn A., Frank P. Vendetti, John Wrangle, et al.. (2011). Abstract LB-411: A phase II study of combination epigenetic therapy in advanced non-small cell lung cancer. Cancer Research. 71(8_Supplement). LB–411. 1 indexed citations

4.

Juergens, Rosalyn A., Frank P. Vendetti, Barbara Coleman, et al.. (2009). Interim analysis of a phase II trial of 5-azacitidine (5AC) and entinostat (SNDX-275) in relapsed advanced lung cancer (NSCLC). Journal of Clinical Oncology. 27(15_suppl). 8055–8055. 10 indexed citations

5.

Juergens, Rosalyn A., Frank P. Vendetti, Barbara Coleman, et al.. (2008). Phase I trial of 5-azacitidine (5AC) and SNDX-275 in advanced lung cancer (NSCLC). Journal of Clinical Oncology. 26(15_suppl). 19036–19036. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact